275 related articles for article (PubMed ID: 27870568)
1. Morbidity and Mortality Differences Between Hematopoietic Cell Transplantation Survivors and Other Cancer Survivors.
Chow EJ; Cushing-Haugen KL; Cheng GS; Boeckh M; Khera N; Lee SJ; Leisenring WM; Martin PJ; Mueller BA; Schwartz SM; Baker KS
J Clin Oncol; 2017 Jan; 35(3):306-313. PubMed ID: 27870568
[TBL] [Abstract][Full Text] [Related]
2. Late Kidney Morbidity and Mortality in Hematopoietic Cell Transplant Survivors.
Wu NL; Hingorani S; Cushing-Haugen KL; Lee SJ; Chow EJ
Transplant Cell Ther; 2021 May; 27(5):434.e1-434.e6. PubMed ID: 33775588
[TBL] [Abstract][Full Text] [Related]
3. Late infectious complications in hematopoietic cell transplantation survivors: a population-based study.
Foord AM; Cushing-Haugen KL; Boeckh MJ; Carpenter PA; Flowers MED; Lee SJ; Leisenring WM; Mueller BA; Hill JA; Chow EJ
Blood Adv; 2020 Apr; 4(7):1232-1241. PubMed ID: 32227211
[TBL] [Abstract][Full Text] [Related]
4. Late Mortality and Causes of Death among Long-Term Survivors after Allogeneic Stem Cell Transplantation.
Atsuta Y; Hirakawa A; Nakasone H; Kurosawa S; Oshima K; Sakai R; Ohashi K; Takahashi S; Mori T; Ozawa Y; Fukuda T; Kanamori H; Morishima Y; Kato K; Yabe H; Sakamaki H; Taniguchi S; Yamashita T;
Biol Blood Marrow Transplant; 2016 Sep; 22(9):1702-1709. PubMed ID: 27246369
[TBL] [Abstract][Full Text] [Related]
5. Comparison of two pretransplant predictive models and a flexible HCT-CI using different cut off points to determine low-, intermediate-, and high-risk groups: the flexible HCT-CI Is the best predictor of NRM and OS in a population of patients undergoing allo-RIC.
Barba P; Piñana JL; Martino R; Valcárcel D; Amorós A; Sureda A; Briones J; Delgado J; Brunet S; Sierra J
Biol Blood Marrow Transplant; 2010 Mar; 16(3):413-20. PubMed ID: 19922807
[TBL] [Abstract][Full Text] [Related]
6. Relapse and late mortality in 5-year survivors of myeloablative allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in first chronic phase.
Goldman JM; Majhail NS; Klein JP; Wang Z; Sobocinski KA; Arora M; Horowitz MM; Rizzo JD
J Clin Oncol; 2010 Apr; 28(11):1888-95. PubMed ID: 20212247
[TBL] [Abstract][Full Text] [Related]
7. Relative survival of long-term hematopoietic cell transplant recipients approaches general population rates.
Nivison-Smith I; Simpson JM; Dodds AJ; Ma DD; Szer J; Bradstock KF
Biol Blood Marrow Transplant; 2009 Oct; 15(10):1323-30. PubMed ID: 19747641
[TBL] [Abstract][Full Text] [Related]
8. Late-occurring infections in a contemporary cohort of hematopoietic cell transplantation survivors.
Sy A; Chanson D; Berano Teh J; Wong FL; Nakamura R; Dadwal S; Armenian SH
Cancer Med; 2021 May; 10(9):2956-2966. PubMed ID: 33835722
[TBL] [Abstract][Full Text] [Related]
9. Impact of Pretransplantation Indices in Hematopoietic Stem Cell Transplantation: Knowledge of Center-Specific Outcome Data Is Pivotal before Making Index-Based Decisions.
Törlén J; Remberger M; Le Blanc K; Ljungman P; Mattsson J
Biol Blood Marrow Transplant; 2017 Apr; 23(4):677-683. PubMed ID: 28063962
[TBL] [Abstract][Full Text] [Related]
10. Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation.
Parikh CR; Schrier RW; Storer B; Diaconescu R; Sorror ML; Maris MB; Maloney DG; McSweeney P; Storb R; Sandmaier BM
Am J Kidney Dis; 2005 Mar; 45(3):502-9. PubMed ID: 15754272
[TBL] [Abstract][Full Text] [Related]
11. Increased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: a report from the FHCRC and the EBMT-Late Effect Working Party.
Friedman DL; Rovo A; Leisenring W; Locasciulli A; Flowers ME; Tichelli A; Sanders JE; Deeg HJ; Socie G; ;
Blood; 2008 Jan; 111(2):939-44. PubMed ID: 17911386
[TBL] [Abstract][Full Text] [Related]
12. Late cardiovascular complications after hematopoietic cell transplantation.
Chow EJ; Wong K; Lee SJ; Cushing-Haugen KL; Flowers ME; Friedman DL; Leisenring WM; Martin PJ; Mueller BA; Baker KS
Biol Blood Marrow Transplant; 2014 Jun; 20(6):794-800. PubMed ID: 24565992
[TBL] [Abstract][Full Text] [Related]
13. Late effects of hematopoietic cell transplantation among 10-year adult survivors compared with case-matched controls.
Syrjala KL; Langer SL; Abrams JR; Storer BE; Martin PJ
J Clin Oncol; 2005 Sep; 23(27):6596-606. PubMed ID: 16170167
[TBL] [Abstract][Full Text] [Related]
14. Second Cancer Risk and Late Mortality in Adult Australians Receiving Allogeneic Hematopoietic Stem Cell Transplantation: A Population-Based Cohort Study.
Vajdic CM; Mayson E; Dodds AJ; O'Brien T; Wilcox L; Nivison-Smith I; Le Marsney R; Daniels B; Ashton LJ;
Biol Blood Marrow Transplant; 2016 May; 22(5):949-56. PubMed ID: 26860637
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantation.
Baron F; Storb R; Storer BE; Maris MB; Niederwieser D; Shizuru JA; Chauncey TR; Bruno B; Forman SJ; McSweeney PA; Maziarz RT; Pulsipher MA; Agura ED; Wade J; Sorror M; Maloney DG; Sandmaier BM
J Clin Oncol; 2006 Sep; 24(25):4150-7. PubMed ID: 16896000
[TBL] [Abstract][Full Text] [Related]
16. Risk and Cause of Death in Patients Diagnosed With Myeloproliferative Neoplasms in Sweden Between 1973 and 2005: A Population-Based Study.
Hultcrantz M; Wilkes SR; Kristinsson SY; Andersson TM; Derolf ÅR; Eloranta S; Samuelsson J; Landgren O; Dickman PW; Lambert PC; Björkholm M
J Clin Oncol; 2015 Jul; 33(20):2288-95. PubMed ID: 26033810
[TBL] [Abstract][Full Text] [Related]
17. Hypertension and diabetes mellitus in adult and pediatric survivors of allogeneic hematopoietic cell transplantation.
Majhail NS; Challa TR; Mulrooney DA; Baker KS; Burns LJ
Biol Blood Marrow Transplant; 2009 Sep; 15(9):1100-7. PubMed ID: 19660723
[TBL] [Abstract][Full Text] [Related]
18. Mortality among 5-year survivors of cancer diagnosed during childhood or adolescence in British Columbia, Canada.
MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Abanto ZU; McBride ML
Pediatr Blood Cancer; 2007 Apr; 48(4):460-7. PubMed ID: 16767717
[TBL] [Abstract][Full Text] [Related]
19. Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study.
Bhatia S; Robison LL; Francisco L; Carter A; Liu Y; Grant M; Baker KS; Fung H; Gurney JG; McGlave PB; Nademanee A; Ramsay NK; Stein A; Weisdorf DJ; Forman SJ
Blood; 2005 Jun; 105(11):4215-22. PubMed ID: 15701723
[TBL] [Abstract][Full Text] [Related]
20. Late mortality after hematopoietic SCT for a childhood malignancy.
Schechter T; Pole JD; Darmawikarta D; Doyle J; Ali M; Egeler M; Gassas A; Irwin MS; Greenberg M; Nathan PC
Bone Marrow Transplant; 2013 Oct; 48(10):1291-5. PubMed ID: 23665822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
